Enhancing Clinical Decision-Making in Gestational Diabetes Through Metabolomics: A Pharmacy Practice Outlook

Abstract

Gestational diabetes mellitus (GDM) is a pregnancy complication associated with glucose intolerance and an increased risk of type 2 diabetes. Metabolic alterations, including changes in amino acids, fatty acids, and glycolysis, have been linked to GDM. However, comprehensive metabolomics analyses, particularly in Middle Eastern women cohort, are lacking. This study aims to identify unique metabolic pathways to enhance understanding of disease progression and guide diagnosis and targeted therapeutic strategies. Blood samples were collected from 32 women with GDM and 21 healthy pregnant women. Metabolomic analysis was performed using trapped ion mobility spectrometry time-of-flight mass spectrometry. Statistical analysis included a two-tailed independent Student’s t-test, with a significance threshold of p < 0.05. Out of 108 identified metabolites student’s t-test analysis revealed 33 statistically significant metabolites (P < 0.05) in GDM group compared to healthy pregnant women. Of them, citramalic acid, creatinine, D-arginine, and glutamine were significantly reduced in GDM, while 4-aminohippuric acid, homovanillic acid, alpha-aspartyl-lysine, L-aspartyl-L-phenylalanine, L-valine, L-leucine, and normetanephrine were increased. Pathway analysis further highlighted phenylacetate metabolism as a key pathway upregulated in GDM. This underscores the potential significance of phenylacetate metabolism in the metabolic alterations associated with GDM. A comprehensive understanding of metabolic alteration in GDM provides valuable insights into the factors influencing the metabolic environment of pregnant women with GDM. This knowledge not only enhances our understanding of the molecular mechanisms underlying GDM but also paves away for developing diagnostic and targeted therapeutic strategies. By addressing dysregulated metabolomic pathways, these findings hold the potential for improving the management and prevention of GDM.